These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35316288)

  • 1. Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time.
    Sprenger R; Häckl D; Kossack N; Schiffner-Rohe J; Wohlleben J; von Eiff C
    PLoS One; 2022; 17(3):e0265433. PubMed ID: 35316288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany.
    Schmedt N; Schiffner-Rohe J; Sprenger R; Walker J; von Eiff C; Häckl D
    PLoS One; 2019; 14(8):e0220848. PubMed ID: 31393931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Did the change of the vaccination schedule effect pneumococcal conjugate vaccination compliance and adherence of premature and mature born infants in Germany? Answers from a claims database analysis.
    Schley K; Borchert K; Seidel K; Jacob C; von Eiff C; Laurenz M
    Vaccine; 2023 Jun; 41(28):4081-4091. PubMed ID: 37263871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination rates and adherence in pneumococcal conjugate vaccination in mature born infants before and after vaccination schedule change - A claims database analysis.
    Laurenz M; von Eiff C; Borchert K; Jacob C; Seidel K; Schley K
    Vaccine; 2021 Jun; 39(24):3287-3295. PubMed ID: 33962835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination rates and adherence in premature infants before and after pneumococcal conjugate vaccine schedule change for term infants - A claims database analysis in Germany.
    Laurenz M; von Eiff C; Borchert K; Jacob C; Seidel K; Schley K
    Vaccine; 2021 Dec; 39(51):7387-7393. PubMed ID: 34852945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal vaccination coverage in individuals (16-59 years) with a newly diagnosed risk condition in Germany.
    Deb A; Podmore B; Barnett R; Beier D; Galetzka W; Qizilbash N; Haeckl D; Boellinger T; Johnson KD; Weiss T
    BMC Infect Dis; 2022 Sep; 22(1):753. PubMed ID: 36171549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of pneumococcal vaccination for infants and children with the conjugate vaccine PnC-7 in Germany.
    Claes C; Graf von der Schulenburg JM
    Pharmacoeconomics; 2003; 21(8):587-600. PubMed ID: 12751916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.
    Cho BH; Stoecker C; Link-Gelles R; Moore MR
    Vaccine; 2013 Dec; 31(50):6011-21. PubMed ID: 24148572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individuals.
    Theidel U; Kuhlmann A; Braem A
    Dtsch Arztebl Int; 2013 Nov; 110(44):743-50. PubMed ID: 24280430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions.
    Vietri J; Harnett J; Emir B; Chilson E
    Hum Vaccin Immunother; 2020; 16(1):161-168. PubMed ID: 31343949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.
    Shigayeva A; Rudnick W; Green K; Chen DK; Demczuk W; Gold WL; Johnstone J; Kitai I; Krajden S; Lovinsky R; Muller M; Powis J; Rau N; Walmsley S; Tyrrell G; Bitnun A; McGeer A;
    Clin Infect Dis; 2016 Jan; 62(2):139-47. PubMed ID: 26354970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
    Loubet P; Kernéis S; Groh M; Loulergue P; Blanche P; Verger P; Launay O
    Vaccine; 2015 Jul; 33(31):3703-8. PubMed ID: 26073016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
    Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
    Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
    Yildirim I; Shea KM; Little BA; Silverio AL; Pelton SI;
    Pediatrics; 2015 Mar; 135(3):495-503. PubMed ID: 25647674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(25):521-4. PubMed ID: 23803961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of vaccination quotas for pneumococcal conjugate vaccine in children on the basis of routine data of the statutory health insurance].
    Theidel U; Braem A; Rückinger S
    Gesundheitswesen; 2013 May; 75(5):309-16. PubMed ID: 23073984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink.
    Costello R; Winthrop KL; Pye SR; Brown B; Dixon WG
    PLoS One; 2016; 11(4):e0153848. PubMed ID: 27096429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.